Search Results - "Grana, Eduardo Climent"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Antiparkinsonian Medication Reconciliation as a Strategy to Improve Safety by Preventing Medication Errors by Viudez‐Martínez, Adrián, Ramírez‐López, Ana, López‐Nieto, Javier, ClimentGrana, Eduardo, Riera, Gerónima

    “…ABSTRACT Background About 70% of neurologists report that PD patients do not get their medication properly when hospitalized, and 33% are prescribed…”
    Get full text
    Journal Article
  2. 2

    Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study by Ramos-Rincon, Jose-Manuel, Moreno-Perez, Oscar, Gomez-Martinez, Nazaret, Priego-Valladares, Manuel, Climent-Grana, Eduardo, Marti-Pastor, Ana, Portilla-Sogorb, Joaquin, Sanchez-Martinez, Rosario, Merino, Esperanza

    Published in Medicina (Kaunas, Lithuania) (26-08-2021)
    “…Background and Objectives: Descriptions of end-of-life in COVID-19 are limited to small cross-sectional studies. We aimed to assess end-of-life care in…”
    Get full text
    Journal Article
  3. 3

    Acute Cholestatic Hepatitis Probably Associated with Risperidone by Tello, Francisca Llinares, Prats, Carmen Hernández, Ros, Nuria Bosacoma, Martínez, Enrique Pérez, Grana, Eduardo Climent, Polo, José Noé Navarro, Baines, Juan Pablo Ordovás

    “…Objective: Risperidone is an atypical neuroleptic drug widely used due to the lower incidence and severity of hepatic adverse effects in comparison to…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily by ARROYO, Elena, VALENZUELA, Belen, PORTILLA, Joaquin, CLIMENT-GRANA, Eduardo, PEREZ-RUIXO, Juan Jose, MERINO, Esperanza

    Published in European journal of clinical pharmacology (01-07-2007)
    “…The effect of nevirapine once-daily dosing on the pharmacokinetics of methadone and its main metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, was…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban by Ordovás Baines, Juan Pablo, Climent Grana, Eduardo, Jover Botella, Alejandro, Valero García, Isabel

    Published in Farmacia hospitalaria (01-05-2009)
    “…Dabigatran is the first available oral direct thrombin inhibitor anticoagulant. Absorption of the prodrug, dabigatran etexilate and its conversion to…”
    Get full text
    Journal Article
  6. 6

    Farmacocinética y farmacodinamia de los nuevos anticoagulantes orales by Ordovás Baines, Juan Pablo, Climent Grana, Eduardo, Jover Botella, Alejandro, Valero García, Isabel

    Published in Farmacia hospitalaria (01-06-2009)
    “…Dabigatran es el primer anticoagulante inhibidor directo de la trombina disponible por vía oral. La absorción del profármaco dabigatran etexilato y su…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Evaluación de un programa de intervención farmacéutica en pacientes con medicamentos de riesgo renal by Álvarez Arroyo, L., Climent Grana, E., Bosacoma Ros, N., Roca Meroño, S., Perdiguero Gil, M., Ordovás Baines, J.P., Sánchez Payá, J.

    Published in Farmacia hospitalaria (01-06-2009)
    “…Comparar la adecuación de las prescripciones médicas según las guías de dosificación, en pacientes con enfermedad renal, antes y después de aplicar un programa…”
    Get full text
    Journal Article